• Integrative Multi-Omics Uncovers ARID1A-Driven Melanoma Resi

  2026-07-28

  This study applies integrative multi-omics to reveal how ARID1A loss in BRAF V600E melanoma cells drives resistance to BRAF/MAPK inhibitors. The findings highlight transcriptional rewiring, sustained MAPK activity, and immune evasion networks, identifying new targets for overcoming drug resistance in melanoma research.

• Tetracycline as a Translational Lever: Bridging Ribosome Bio

  2026-07-28

  This thought-leadership article explores how tetracycline, a broad-spectrum polyketide antibiotic, is redefining its role in translational research. By integrating the latest mechanistic discoveries—including ribosomal function modulation, antibiotic selection, and cellular stress modeling—with strategic guidance for experimentalists, we chart a course for harnessing tetracycline’s full potential. Drawing on product intelligence from APExBIO and recent landmark studies on cellular senescence and telomerase regulation, this piece provides a roadmap for innovation in both fundamental and disease-oriented research.

• Cell lysis buffer for WB and IP: Optimizing Protein Extracti

  2026-07-27

  Unlock robust, reproducible protein extraction—even from challenging tumor microenvironments—using the Cell lysis buffer for WB and IP. This buffer's advanced protease and phosphatase inhibitor cocktail ensures native protein integrity, making it ideal for sensitive downstream assays like Western blot and immunoprecipitation.

• (S)-(+)-Methoprene: Dissecting Juvenile Hormone Signaling Ne

  2026-07-27

  (S)-(+)-Methoprene is a potent juvenile hormone analog essential for unraveling the molecular complexity of insect development. This article uniquely explores how (S)-(+)-Methoprene enables advanced mechanistic studies of hormone-regulated gene networks and miRNA–mRNA modules, providing deeper insights for developmental biology and toxicology research.

• Azilsartan (TAK-536): Optimizing RAS–SIRT3 Assays in Neuroin

  2026-07-26

  Leverage Azilsartan's potent AT1 antagonism for precise dissection of the renin-angiotensin system in astrocyte–microglia models. This guide details advanced workflows, troubleshooting strategies, and the unique translational value unlocked by APExBIO's high-purity Azilsartan in neuroinflammation and cardiovascular research.

• Cy5 Hydrazide (Non-sulfonated): Reliable Carbonyl Labeling i

  2026-07-25

  This article details how Cy5 hydrazide (non-sulfonated, SKU A8145) overcomes key challenges in protein carbonylation labeling, oxidative stress detection, and nanotechnology workflows. Grounded in peer-reviewed data and real laboratory scenarios, it offers practical guidance on optimizing reproducibility, sensitivity, and cost-efficiency for biomedical researchers and laboratory technicians.

• Benzyl-Activated Streptavidin Magnetic Beads: Optimizing Ear

  2026-07-24

  Discover how Benzyl-activated Streptavidin Magnetic Beads empower precise, low-background biotinylated molecule capture in advanced cell death and protein interaction assays. Uncover unique mechanistic insights, practical assay optimization, and scientific breakthroughs that distinguish this approach from existing methodologies.

• RNA Pol II Degradation Triggers Apoptosis Beyond Transcripti

  2026-07-24

  Harper et al. (2025) demonstrate that cell death from RNA Pol II inhibition results from active apoptotic signaling, not simply the loss of transcription. This mechanistic insight redefines how RNA Pol II-targeted drugs induce lethality, with implications for apoptosis assay design and cancer research.

• Palonosetron Hydrochloride in Preventing Chemotherapy-Induce

  2026-07-23

  This article examines the clinical innovation and pharmacologic basis for palonosetron hydrochloride as a 5-HT3 receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting (CINV). The reference study highlights palonosetron’s distinct efficacy in delayed-phase CINV relative to other agents, suggesting optimized supportive care protocols for antineoplastic chemotherapy regimens.

• ARCA Cy5 EGFP mRNA (5-moUTP): Benchmarking mRNA Delivery Ass

  2026-07-23

  ARCA Cy5 EGFP mRNA (5-moUTP) empowers researchers with dual-fluorescence and 5-methoxyuridine modification, streamlining mRNA localization and translation assays. Its robust design minimizes innate immune activation and provides unmatched clarity for troubleshooting and optimizing mRNA delivery systems.

• Ziprasidone HCl Inhibits GOT1 and Alters Glutamine Metabolis

  2026-07-22

  The referenced study demonstrates that Ziprasidone HCl acts as a novel non-competitive inhibitor of GOT1, disrupting glutamine metabolism and redox balance in pancreatic ductal adenocarcinoma (PDAC) cells. These findings suggest a potential therapeutic approach for targeting metabolic vulnerabilities in pancreatic cancer.

• URB597 (KDS-4103): Redefining FAAH Inhibition for Translatio

  2026-07-22

  Explore how URB597 (KDS-4103), a potent and selective FAAH inhibitor from APExBIO, is transforming translational research in pain, neuroinflammation, and neuroplasticity. This thought-leadership article bridges mechanistic insights with practical guidance on leveraging URB597 in preclinical models, contextualizes its unique value against evolving paradigms, and provides protocol parameters for optimal in vivo and in vitro use, all while drawing on recent cannabinoid research and cross-referencing leading studies.

• Optimizing Cell Assays with Benzyl-activated Streptavidin Ma

  2026-07-21

  This article explores real laboratory scenarios where Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) deliver reproducible, high-sensitivity solutions for cell viability, proliferation, and cytotoxicity assays. By grounding recommendations in published data and practical workflows, biomedical researchers and lab technicians can confidently leverage SKU K1301 to address bottlenecks in protein and nucleic acid purification, immunoprecipitation, and protein interaction studies.

• Cytochalasin B in Pathogen Entry Assays: Beyond Cytoskeletal

  2026-07-21

  Explore how Cytochalasin B (NSC 107658) enables advanced dissection of actin-dependent pathogen entry, with fresh insights from invertebrate cell models. This article reveals unique assay strategies and mechanistic depth for cytoskeletal research.

• Nifedipine (BAY-a-1040): Applied Calcium Influx Inhibition W

  2026-07-20

  Nifedipine (BAY-a-1040) offers precise, reproducible inhibition of L-type calcium channels, enabling advanced research in cardiac, hepatic, and microbial systems. This guide details experimental workflows, protocol enhancements, and evidence-driven troubleshooting for translational scientists leveraging APExBIO’s high-purity Nifedipine.

17021 records 1/1135 page Next 12345 下5页 Last page